Systemic Lupus and Other Autoimmune Disorders During Pregnancy

Area of Science:

• Obstetrics and Gynecology
• Rheumatology
• Maternal-Fetal Medicine

Background:

• Rheumatologic conditions are prevalent in women of reproductive age.
• Managing these conditions during pregnancy necessitates a multidisciplinary care model involving obstetrics, maternal-fetal medicine, and rheumatology specialists.
• Optimizing patient care requires careful consideration of medication safety and disease control throughout pregnancy.

Purpose of the Study:

• To highlight the importance of a coordinated, multidisciplinary approach for managing rheumatologic conditions in women of reproductive age.
• To emphasize the need for preconception medication review to ensure the safest regimen for both mother and fetus.
• To discuss the specific risks associated with anti-Ro/SSA and anti-La/SSB antibodies, such as neonatal lupus syndrome.

Main Methods:

• Review of current medical literature and clinical guidelines.
• Emphasis on multidisciplinary team collaboration.
• Discussion of preconception counseling and ongoing antenatal surveillance.

Main Results:

• Many medications used for rheumatologic conditions can be safely continued during pregnancy after careful review.
• Anti-Ro/SSA and anti-La/SSB antibodies present specific risks, including potential cardiac manifestations in neonatal lupus syndrome.
• Individualized medical management, including ultrasounds and antenatal testing, is essential for optimizing maternal and fetal outcomes.

Conclusions:

• A collaborative, multidisciplinary approach is vital for managing rheumatologic conditions in pregnant women.
• Preconception planning and medication optimization are key to minimizing risks.
• Vigilant monitoring for maternal and fetal well-being is crucial throughout pregnancy, especially in the presence of specific antibodies.